EMBC Net Income Growth
5.55%TTM
Period ending:
EMBC TTM Net Income YoY %%
170.05%-113.47%
2022-09-302026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
EMBC net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 16 observations from Sep 30, 2022 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 5.5489% | |
| 114.7793% | |
| 142.6087% | |
| 20.9451% | |
| 18.9383% | |
| -25.7835% | |
| 3.9783% | |
| 11.2216% | |
| 47.6695% | |
| -25.6356% | |
| -65.4375% | |
| -68.5152% | |
| -86.0314% | |
| -75.171% | |
| -60.8323% | |
| -46.1205% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All EMBC financial metrics · EMBC stock overview · How to interpret financial metrics
